Merck posts quarterly loss due to Cidara charge, sales rise 5%
By Deena Beasley April 30 (Reuters) - Merck & Co on Thursday reported a loss for the first quarter as an acquisition-related charge offset a 5% increase in product sales driven by cancer and respiratory drugs. 
